Jan H. Rüschoff

2.6k total citations · 1 hit paper
51 papers, 1.4k citations indexed

About

Jan H. Rüschoff is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Surgery. According to data from OpenAlex, Jan H. Rüschoff has authored 51 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 20 papers in Molecular Biology and 11 papers in Surgery. Recurrent topics in Jan H. Rüschoff's work include Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Cancer Genomics and Diagnostics (7 papers). Jan H. Rüschoff is often cited by papers focused on Prostate Cancer Treatment and Research (13 papers), Prostate Cancer Diagnosis and Treatment (9 papers) and Cancer Genomics and Diagnostics (7 papers). Jan H. Rüschoff collaborates with scholars based in Switzerland, Germany and United States. Jan H. Rüschoff's co-authors include Niels J. Rupp, Thomas Hermanns, Holger Moch, Peter J. Wild, Christian D. Fankhauser, Michaël Moret, Eirini Arvaniti, Manfred Claassen, Norbert Wey and Irene A. Burger and has published in prestigious journals such as Cancer Cell, Scientific Reports and Radiology.

In The Last Decade

Jan H. Rüschoff

46 papers receiving 1.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer

2024 124 citations Martina Haberecker, Jan H. Rüschoff et al. profile →

Peers

Countries citing papers authored by Jan H. Rüschoff

Since Specialization

Citations

This map shows the geographic impact of Jan H. Rüschoff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan H. Rüschoff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan H. Rüschoff more than expected).

Fields of papers citing papers by Jan H. Rüschoff

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan H. Rüschoff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan H. Rüschoff. The network helps show where Jan H. Rüschoff may publish in the future.

Co-authorship network of co-authors of Jan H. Rüschoff

This figure shows the co-authorship network connecting the top 25 collaborators of Jan H. Rüschoff. A scholar is included among the top collaborators of Jan H. Rüschoff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan H. Rüschoff. Jan H. Rüschoff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Towards Reliable Methodology: Microbiome Analysis of Fresh Frozen vs. Formalin-Fixed Paraffin-Embedded Bladder Tissue Samples: A Feasibility Study 2024 ·Microorganisms ·(unknown), (unknown), (unknown), Yasser Morsy, Michael Scharl, Jan H. Rüschoff, Lukas J. Hefermehl, (unknown), (unknown), Daniel Engeler, Beat Foerster, (unknown), (unknown), (unknown), Daniel Eberli, Cédric Poyet	1
2	Pleural Effusion Caused by an Unusual Mass in the Right Hemithorax 2024 ·CHEST Journal ·(unknown), (unknown), (unknown), Jan H. Rüschoff, Peter K. Bode, Corina Dommann‐Scherrer	0
3	Immunohistochemical ERG positivity is associated with decreased PSMA expression and lower visibility in corresponding [68Ga]Ga-PSMA-11 PET scans of primary prostate cancer 2024 ·European Journal of Nuclear Medicine and Molecular Imaging ·Niels J. Rupp, Sandra N. Freiberger, Daniela A. Ferraro, Riccardo Laudicella, Jakob Heimer, Urs J. Muehlematter, Cédric Poyet, Holger Moch, Daniel Eberli, Jan H. Rüschoff, Irene A. Burger	6
4	Testing for deficient mismatch repair and microsatellite instability 2023 ·PubMed ·Josef Rüschoff, Hans‐Ulrich Schildhaus, Jan H. Rüschoff, Korinna Jöhrens, Tina Bocker Edmonston, Wolfgang Dietmaier, Hendrik Bläker, Gustavo Baretton, David Horst, Manfred Dietel, Arndt Hartmann, Frederick Klauschen, Sabine Merkelbach‐Bruse, Albrecht Stenzinger, Sandra Schöniger, Markus Tiemann, Wilko Weichert, Reinhard Büttner	10
5	Infiltrative growth pattern of prostate cancer is associated with lower uptake on PSMA PET and reduced diffusion restriction on mpMRI 2022 ·European Journal of Nuclear Medicine and Molecular Imaging ·Riccardo Laudicella, Jan H. Rüschoff, Daniela A. Ferraro, Muriel Brada, Daniel Hausmann, (unknown), Alexander Maurer, Thomas Hermanns, Daniel Eberli, Niels J. Rupp, Irene A. Burger	23
6	Identification of Urine Biomarkers to Improve Eligibility for Prostate Biopsy and Detect High-Grade Prostate Cancer 2022 ·Cancers ·(unknown), (unknown), (unknown), Arnas Rakauskas, Valérie Cesson, Karim Saba, Thomas Hermanns, (unknown), (unknown), Maurizio Provenzano, Jan H. Rüschoff, Muriel Brada, Niels J. Rupp, Cédric Poyet, Laurent Derré, Massimo Valério, Irina Banzola, Daniel Eberli	8
7	Prospective observational study of the role of the microbiome in BCG responsiveness prediction (SILENT-EMPIRE): a study protocol 2022 ·BMJ Open ·(unknown), Michael Scharl, (unknown), Barbara M. Szczerba, Yasser Morsy, Jan H. Rüschoff, Peter Schraml, Michael Krauthammer, (unknown), Daniel Eberli, Cédric Poyet	12
8	Prognostic impact of tumour mutational burden in resected stage I and II lung adenocarcinomas from a European Thoracic Oncology Platform Lungscape cohort 2022 ·Lung Cancer ·Lukas Bubendorf, Martin Zoche, Urania Dafni, Jan H. Rüschoff, Spasenija Savic Prince, Nesa Marti, (unknown), Roswitha Kammler, Stephen P. Finn, Holger Moch, Solange Peters, Rolf A. Stahel	4
9	Targeting ALK in Neuroendocrine Tumors of the Lung 2022 ·Frontiers in Oncology ·Dilara Akhoundova, Martina Haberecker, Ralph Fritsch, Sylvia Höller, Michael K. Kießling, Markus Rechsteiner, Jan H. Rüschoff, Alessandra Curioni‐Fontecedro	16
10	The Morphological Spectrum of Papillary Renal Cell Carcinoma and Prevalence of Provisional/Emerging Renal Tumor Entities with Papillary Growth 2021 ·Biomedicines ·João Lobo, Riuko Ohashi, Birgit Helmchen, Niels J. Rupp, Jan H. Rüschoff, Holger Moch	21
11	A novel 5x multiplex immunohistochemical staining reveals PSMA as a helpful marker in prostate cancer with low p504s expression. 2021 ·Pathology - Research and Practice ·Jan H. Rüschoff, Steven P. Stratton, Esteban Roberts, (unknown), (unknown), Christian D. Fankhauser, Daniel Eberli, Holger Moch, Peter J. Wild, Niels J. Rupp	5
12	Photon-counting CT with tungsten as contrast medium: Experimental evidence of vessel lumen and plaque visualization 2020 ·Atherosclerosis ·Thomas Sartoretti, Matthias Eberhard, Jan H. Rüschoff, Hubertus Pietsch, Gregor Jošt, Tristan Nowak, Bernhard Schmidt, Thomas Flohr, André Euler, Hatem Alkadhi	27
13	Diagnostic Accuracy of Multiparametric MRI versus ⁶⁸Ga-PSMA-11 PET/MRI for Extracapsular Extension and Seminal Vesicle Invasion in Patients with Prostate Cancer 2019 ·Radiology ·Urs J. Muehlematter, Irene A. Burger, Anton S. Becker, Khoschy Schawkat, Andreas M. Hötker, Cäcilia S. Reiner, Julian Müller, Niels J. Rupp, Jan H. Rüschoff, Daniel Eberli, Olivio F. Donati	87
14	Expression and Mutation Patterns of PBRM1, BAP1 and SETD2 Mirror Specific Evolutionary Subtypes in Clear Cell Renal Cell Carcinoma 2019 ·Neoplasia ·(unknown), Riuko Ohashi, (unknown), Jan H. Rüschoff, Christian Beisel, Thomas Hermanns, Axel Mischo, Claudia Corrò, J. Beyer, Niko Beerenwinkel, Holger Moch, Peter Schraml	47
15	A curated collection of tissue microarray images and clinical outcome data of prostate cancer patients 2017 ·Scientific Data ·Qing Zhong, Tiannan Guo, Markus Rechsteiner, Jan H. Rüschoff, Niels J. Rupp, Christian D. Fankhauser, Karim Saba, Ashkan Mortezavi, Cédric Poyet, Thomas Hermanns, Yi Zhu, Holger Moch, Ruedi Aebersold, Peter J. Wild	18
16	Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09) 2014 ·European Urology ·Christian Rothermundt, Stefanie Hayoz, Arnoud J. Templeton, (unknown), Räto T. Strebel, Daniela Bärtschi, Michaël Pollak, (unknown), Kathrin Endt, Ralph Schiess, Jan H. Rüschoff, Richard Cathomas, Silke Gillessen	92
17	KRAS, BRAF, and TP53 Deep Sequencing for Colorectal Carcinoma Patient Diagnostics 2013 ·Journal of Molecular Diagnostics ·Markus Rechsteiner, Adriana von Teichman, Jan H. Rüschoff, Niklaus Fankhauser, Bernhard C. Pestalozzi, Peter Schraml, Achim Weber, Peter J. Wild, Dieter R. Zimmermann, Holger Moch	27
18	SO<sub>2</sub>-Induced Enhancement of Inhalative Allergic Sensitization Inhibition by Anti-Inflammatory Treatment 1992 ·International Archives of Allergy and Immunology ·Frank Riedel, (unknown), Jan H. Rüschoff, (unknown), C. Rieger	8
19	Silver-Stained Structures in Prostatic Carcinoma: Evaluation of Diagnostic and Prognostic Relevance by Automated Image Analysis 1991 ·Urologia Internationalis ·(unknown), Jan H. Rüschoff, (unknown), (unknown), Kevin Neumann, Wolfgang Schultze‐Seemann, (unknown)	29
20	A cytofluorometric method to quantify membrane antigens on individual alveolar macrophages 1990 ·Journal of Immunological Methods ·(unknown), K Neumann, Jan H. Rüschoff, Jochen Heymanns, P. von Wichert	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact